Quality assurance in follow-up and initial treatment for screening mammography programs in 22 countries

International Journal for Quality in Health Care

Volumn 14, Issue 6, 2002, Pages 449-461

  Klabunde, Carrie N ^a   Sancho Garnier, Hélène ^b,f   Taplin, Stephen ^c,f   Thoresen, Steinar ^d   Ohuchi, Noriaki ^e   Ballard Barbash, Rachel ^a   Jha, P ^f   Chapple, B ^f   Grivegnee A ^f   Bouchard, F ^f   Lynge, E ^f   Hakama, M ^f   Stines, J ^f   von Karsa, L ^f   Garas, I ^f   Linos, A ^f   Riza, E ^f   Szabo E ^f   Petranyi A ^f   Sigfusson B F ^f   Buttimer, J ^f   Rennert, G ^f   Paci, E ^f   Gentile, E ^f   del Turco, M Rosselli ^f   Ohuchi, N ^f   Scharpantgen, A ^f   Broeders, M ^f   Holland, R ^f   Hendricks, J ^f   Siekman, K ^f   Fracheboud, J ^f   de Koning, H ^f   Skare, G ^f   Rodrigues, V ^f   Ascunce, N ^f   Malmquist, H ^f   Svane, G ^f   Moss, S ^f   Cooke, J ^f   Patnick, J ^f   Pou, G ^f   Yankaskas, B ^f   Hendrick, E ^f   Barlow, W ^f   Bouchard, Francoise ^f   Codd, Mary ^f   Grivegnée, Andre ^f   Hendrick, Edward ^f   Klabunde, Carrie ^f   Pau, Gonzalo ^f   Rodrigues, Vitor ^f   Scharpantgen, Astrid ^f   more..

^a NATIONAL CANCER INSTITUTE   (United States)

^b Epidaure   (France)

^c CENTER FOR HEALTH STUDIES   (United States)

^d CANCER REGISTRY OF NORWAY   (Norway)

^e TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f NONE

Author keywords

Breast Cancer; Follow up; Mammography; Quality assurance; Screening; Treatment

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER MORTALITY; CANCER SCREENING; CLINICAL PROTOCOL; CONTROLLED STUDY; CYTOPATHOLOGY; DATA ANALYSIS; FEMALE; FOLLOW UP; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH PROGRAM; HEALTH SURVEY; HISTOPATHOLOGY; HUMAN; INFORMATION PROCESSING; MAMMOGRAPHY; MASS SCREENING; PRIORITY JOURNAL; QUESTIONNAIRE; STANDARD;

BREAST NEOPLASMS; CANADA; EUROPE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFORMATION STORAGE AND RETRIEVAL; ISRAEL; JAPAN; MAMMOGRAPHY; MASS SCREENING; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PROGRAM EVALUATION; QUALITY ASSURANCE, HEALTH CARE; UNITED STATES; URUGUAY;

EID: 0036936837     PISSN: 13534505     EISSN: None     Source Type: Journal    
DOI: 10.1093/intqhc/14.6.449     Document Type: Article

References (29)

1. National Cancer Institute Applied Research Program. The International Breast Cancer Screening Network: http://www-dccps.ims.nci.nih.gov/ARP/ibsn.html Accessed 11 July 2002.
2. de Wolf CJM, Perry NM, eds. European Guidelines for Quality Assurance in Mammography Screening, 2nd edn. Luxembourg: European Commission, Europe Against Cancer Programme, 1996.
3. Health Canada. Organized Breast Cancer Screening Programs in Canada: 1997 and 1998 Report. Minister of Public Works and Government Services Canada, Ottawa, 2001.
4. Centers for Disease Control and Prevention. Strategies for providing follow-up and treatment services in the National Breast and Cervical Cancer Early Detection Program-United States, 1997. J Am Med Assoc 1998; 279: 1941-1942.
5. Burack RC, Simon MS, Stano M, George J, Coombs J. Follow-up among women with an abnormal mammogram in an HMO: is it complete, timely, and efficient? Am J Manag Care 2000; 6: 1102-1113.
6. Day NE, Williams DRR, Khaw KT. Breast cancer screening programmes: the development of a monitoring and evaluation system. Br J Cancer 1989; 59: 954-958.
7. McCann J, Wait S, Seradour B, Day N. A comparison of the performance and impact of breast cancer screening programmes in East Anglia, U.K. and Bouches du Rhone, France. Eur J Cancer 1997; 33: 429-435.
8. Paci E, Boer R, Zappa M, de Koning HJ et al. A model-based prediction of the impact on reduction in mortality by a breast cancer screening programme in the city of Florence, Italy. Eur J Cancer 1995; 31A: 348-353.
9. Van den Akker-van Marle E, de Koning H, Boer R, van der Maas P. Reduction in breast cancer mortality due to the introduction of mass screening in the Netherlands: comparison with the United Kingdom. J Med Screen 1999; 6: 30-34.
10. Jonsson H, Tornberg S, Nystrom L, Lenner P. Service screening with mammography in Sweden: evaluation of effects of screening on breast cancer mortality in age group 40-49 years. Acta Oncologica 2000; 39: 617-623.
11. Blanks RG, Moss SM, McGahan CE, Quinn MJ, Babb PJ. Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990-8: comparison of observed with predicted mortality. Br Med J 2000; 321: 665-669.
12. Last JM. A Dictionary of Epidemiology, 3rd edn. New York: Oxford University Press, 1995.
13. Shapiro S, Coleman EA, Broeders M et al. Breast cancer screening programmes in 22 countries: current policies, administration, and guidelines. Int J Epidemiol 1998; 27: 735-742.
14. Ballard-Barbash R, Klabunde C, Paci E et al. Breast cancer screening in 21 countries: delivery of services, notification of results, and outcomes ascertainment. Eur J Cancer Prev 1999; 8: 417-426.
15. Klabunde C, Bouchard F, Taplin S, Scharpantgen A, Ballard-Barbash R. Quality assurance for screening mammography: an international comparison. J Epidemiol Community Health 2001; 55: 204-212.
16. Klabunde CN, Sancho-Garnier H, Broeders M, Thoresen S, Rodrigues VJL, Ballard-Barbash R. Quality assurance for screening mammography data collection systems in 22 countries. Int J Technol Assess Health Care 2001; 17: 528-541.
17. Hendrick E, Klabunde C, Grivegnee A, Pou G, Ballard-Barbash R. Technical quality control practices in mammography screening programs in 22 countries. Int J Qual Health Care 2002; 14: 219-226.
18. Bassett LW, Hendrick RE, Bassford TL et al. Quality Determinants of Mammography: Clinical Practice Guideline No. 13. AHCPR Publication No. 95-0632. Rockville, MD: Agency for Health Care Policy and Research, Public Health Service, U.S. Department of Health and Human Services, 1994.
19. National Health Service Breast Screening Programme. Guidelines on Quality Assurance Visits. Sheffield: NHSBSP Publication No. 40, 1998.
20. National Program for the Early Detection of Breast Cancer. National Accreditation Requirements. Canberra: Commonwealth Department of Health and Human Services, 1994.
21. Ballard-Barbash R, Taplin SH, Yankaskis BC et al. Breast cancer surveillance consortium: a national mammography screening and outcomes database. Am J Roentgenol 1997; 169: 1001-1008.
22. Donabedian A. Explorations in Quality Assessment and Monitoring. Volume I: the Definition of Quality and Approaches to its Assessment. Chicago, IL: Health Administration Press, 1980.
23. Linver MN, Osuch JR, Brenner RJ, Smith RA. The mammography audit: a primer for the Mammography Quality Standards Act (MQSA). Am J Roentgenol 1995; 165: 19-25.
24. National Health Service Breast Screening Programme. Guidelines for Breast Pathology Services, 2nd edn. Sheffield: NHSBSP Publication No. 2, 1997.
25. National Health Service Breast Screening Programme. Guidelines for Cytology Procedures and Reporting in Breast Cancer Screening. Sheffield: NHSBSP Publication No. 22, 1993.
26. National Health Service Breast Screening Programme. Quality Assurance Guidelines for Surgeons in Breast Cancer Screening. Sheffield: NHSBSP Publication No. 20, 1996.
27. Working Group on the Integration of Screening and Diagnosis for the Canadian Breast Cancer Screening Initiative. Waiting for a Diagnosis After an Abnormal Breast Screen in Canada. Health Canada. Catalog No. H39-526/2000E, Health Canada, Ottawa; Canada, 2000.
28. Jonsson H, Tornberg S, Nystrom L, Lenner P. Service screening with mammography in Sweden: evaluation of effects of screening on breast cancer mortality in age group 40-49 years. Acta Oncologica 2000; 39: 617-623.
29. Fracheboud J, de Koning HJ, Boer R et al Nationwide breast cancer screening programme fully implemented in the Netherlands. Breast 2001; 10: 6-11.